Related Experiment Video
Updated: May 9, 2026
03:59
Surgical Correction for Pediatric Epiblepharon and Trichiasis
Published on: July 8, 2025
Myectomy for blepharospasm 2013.
Brett Pariseau1, Michael W Worley, Richard L Anderson
1Center for Facial Appearances, Salt Lake City, Utah 84102, USA.
Current Opinion in Ophthalmology
|August 9, 2013
Summary
Myectomy is a crucial surgical option for blepharospasm when botulinum toxin (BTX) injections fail or are unsuitable. It is particularly indicated for patients with eyelid opening apraxia (ALO) and BTX-resistant cases.
Area of Science:
- Ophthalmology
- Neurology
- Surgical Procedures
Background:
- Botulinum toxin (BTX) is a primary treatment for facial dystonias like benign essential blepharospasm (BEB).
- BTX injections are not universally effective, necessitating alternative treatments for some patients.
Purpose of the Study:
- This review focuses on the indications and surgical techniques for myectomy in treating BEB.
- It specifically addresses myectomy for patients with apraxia of eyelid opening (ALO).
Main Methods:
- The review synthesizes current literature on myectomy for BEB and ALO.
- It outlines the surgical approach and patient selection criteria for myectomy.
Main Results:
- Myectomy is indicated for BEB patients with associated ALO.
- It is also considered for those with blepharospasm-associated deformities.
- Patients unresponsive to BTX, or unable to afford/refuse BTX, are also candidates for myectomy.
Conclusions:
- Myectomy remains a vital surgical intervention for managing blepharospasm.
- The most frequent indication for myectomy in BEB patients is the presence of associated ALO.
More Related Videos
Related Concept Videos
01:11Direct-Acting Cholinergic Agonists: Therapeutic Uses
Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren syndrome.
01:20Muscles of the Eye
The muscles of the eye are sophisticated structures that control eye movement and focus, allowing for the precise and rapid adjustments necessary for vision. The human eye is controlled by ten muscles — six extraocular muscles, three intraocular muscles, and one primary eyelid retractor muscle.
Extraocular Muscles
The six extraocular muscles surround the eyeball and control its movements. They are responsible for a wide range of eye motions, including looking up, down, left, right, and rotating...
Extraocular Muscles
The six extraocular muscles surround the eyeball and control its movements. They are responsible for a wide range of eye motions, including looking up, down, left, right, and rotating...
01:28Angle Closure Glaucoma: Treatment
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
01:27Open Angle Glaucoma: Treatment
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
01:20Myasthenia Gravis: Overview and Treatment
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
01:17Accessory Structures of the Eye
Optical perception, or vision, is an extraordinary sense dependent on converting light signals received via the ocular organs. These organs, known as eyes, are securely positioned within the bony cavities of the skull, called orbits. The orbits serve a dual purpose: a protective shield for the ocular globes and a stable attachment point for the soft ocular tissues. The eye's external protective mechanisms include the eyelids, which are edged with lashes that act as a barrier against foreign...